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Simple Summary: Diagnosis of prostatic neoplasia in dogs remains critical since none of the di-
agnostic methods routinely performed seem to have sufficient sensitivity or specificity. In recent
years, contrast-enhanced ultrasound of the prostate gland has been successfully performed in intact
dogs. However, data regarding the performance of the technique in castrated dogs have not been
provided, despite the incidence of prostate neoplasia potentially being higher after castration. The
purpose of the present study was to evaluate the application of contrast-enhanced ultrasound in
castrated dogs and to describe the vascular pattern of the canine prostate. Prior to contrast-enhanced
ultrasound evaluation, B-mode ultrasound was performed to assess prostate size and parenchymal
features. In all cases, perfusion kinetics of the contrast agent within the prostate was analyzed,
with the aim of detecting any areas with increased microvessel density. None of the dogs had any
ultrasonographically detected pathology. Contrast ultrasound allowed an improved and enhanced
ability to evaluate the prostate compared with B-mode ultrasound. This technique is not yet to
become a first-choice diagnostic tool; however, since the results of this study are favorable, it seems
likely that contrast ultrasound will have an important role in the future for the detection of prostate
pathologies in neutered dogs.
Abstract: Prostatic neoplasia (PN) occurs in 5–7% of dogs with prostatic disease, with castrated dogs
having the same or higher prevalence when compared to intact dogs. Considering the promising
results achieved by performing contrast-enhanced ultrasound (CEUS) in intact dogs to detect PN,
the present study aimed to acquire data on the prostatic perfusion pattern in neutered dogs. CEUS
was performed in 64 neutered dogs, using a 5–7.5 MHz linear transducer with coded harmonic
capability, dedicated analytical software, and a second-generation contrast agent, SonoVue. After
B-mode evaluation was performed to assess mean prostate volume, the CEUS examination was
undertaken. The flow of contrast agent was visible 10 s after injection. The subcapsular vessels
were highlighted and produced rapid peripheral rim enhancement. Subsequently, the contrast agent
reached the prostatic urethra via the parenchymal arterioles and gradually reached the entire prostate.
Perfusion peak intensity (PPI) and time to peak (TTP) values were respectively 45.3% and 34.1 s. The
measured parameters were compared with those obtained in previous studies on intact dogs with
normal and with pathological patterns. In this study, CEUS showed features that may be promising
for its use as a diagnostic tool for early detection of PN in neutered dogs.
Keywords: contrast-enhanced ultrasound; B-mode ultrasound; prostate; neutered dogs
1. Introduction
Prostate neoplasia (PN) is a rare disease (prevalence of 0.43%) in both intact and
neutered dogs [1], with Shetland Sheepdogs and Scottish Terriers at increased risk [2].
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The mean age of diagnosis is 10 years. Adenocarcinoma, transitional cell carcinoma, and
undifferentiated carcinoma are the most frequently reported PN [3–6].
A higher prevalence of PN is seen in neutered dogs; however, both neutered and intact
animals develop it at the same age. This aspect suggests that neutering is not an initiator
of cancer, but promotes tumor progression [2,6], or at least does not protect against the
development of neoplasia.
Neutering is a routine surgical procedure in dogs and results in a decrease in testos-
terone and its active metabolite DHT (dihydrotestosterone) in the general circulation. The
reduction of these hormones leads to prostate shrinkage and a decrease in sexual behavior,
resulting in infertility [7,8]. In the last two decades, several studies have shown a statis-
tically significant increased risk of diagnosis of various neoplastic diseases in neutered
males and females compared to intact dogs, which has sparked an international debate on
whether elective neutering is still a tool that should be routinely performed [9,10]. How-
ever, a definitive explanation of how the absence of gonadal hormones may influence the
development of neoplasia in reproductive or nonreproductive tissues is still pending [11].
Early diagnosis of PN in dogs remains challenging, because of the lack of specific
tumor markers found in tissue, blood, bone marrow, or other body fluids; therefore, the
true incidence of prostate cancer may be higher than currently thought [6].
The first step in a PN diagnosis is digital rectal examination, which may provide
information about prostate disorders [12,13]. When a prostate gland with PN is palpated,
it may be felt as an oversized, irregular, immobile, asymmetric mass that may occasionally
cause pain when touched [14]. In normal dogs, surgical castration results in a 70% reduction
in the size of the gland. Although this process begins as early as 7–14 days after neutering,
complete regression of the gland can be expected by 4 months [7]. Nevertheless, the
assessment of prostate size may not be useful to differentiate between malignant and
benign prostate conditions [15].
On B-mode ultrasound, the prostate may appear increased in dimension and asym-
metrical, with irregular and poorly defined outlines. Focal or diffuse, hyperechoic, or
mixed lesions may be found throughout the parenchyma. Hyperechoic foci with acous-
tic shadowing representing mineralization and cavitary, cyst-like lesions varying in size,
shape, and number may also be present. Extension of pathologic changes to the urethra
or bladder neck, enlargement of regional lymph nodes, and disruption of the capsule are
threatening ultrasound signs suggestive of neoplasia [5,16,17]. Interestingly, neutered dogs
with prostatic mineralization are likely to have PN, unlike intact male dogs with prostatic
mineralization, which may be affected by either neoplastic or non-neoplastic prostatic
disease [15].
Histological evaluation by ultrasound-guided fine needle aspiration (FNA) has been
shown to be the most accurate test for detecting PN. Nevertheless, due to the low contrast
and specificity existing between malignant areas and normal tissues on ultrasound images,
nontargeted 12-site systematic biopsies covering the whole prostate gland are often per-
formed to detect neoplasia, causing unnecessary pain to the patient [18–20]. Therefore, due
to the lack of specific tumor ultrasonographic patterns, it is of great importance to develop
innovative imaging techniques to increase the sensitivity and specificity of prostate cancer
screening at an early stage, which may become very helpful to collect fewer and targeted
samples, thereby reducing pain and stress.
The staging of canine PN should include a computed tomography scan, which may
potentially be performed before cytological or histological results are available [20,21].
Magnetic resonance imaging and scintigraphy are rarely performed [4,22].
In recent years, new advanced ultrasound techniques have been undertaken for
the detection of prostate cancer in dogs, such as color and pulsed Doppler sonography,
contrast-enhanced ultrasound (CEUS) [23], and elastography [24].
In veterinary medicine, CEUS has been used successfully to accurately detect the
perfusion patterns of the liver, spleen, and kidneys in healthy dogs [24,25] and showed
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some differences between malignant and benign hepatic, renal, and splenic nodules in
dogs and cats as a function of perfusion patterns [26,27].
CEUS is a technique that uses a specific contrast agent injected into the vessels,
to highlight the small vascular bed. The contrast agent mainly constitutes microbubbles
consisting of a gas core and a stabilized biological shell [28]. Despite there being few studies
about CEUS, this method may be performed to collect detailed information about lesions
and to distinguish a benign lesion from a malignant one, by evaluating prostate gland
vascularization [28,29]. Unlike color Doppler sonography, CEUS allows measurement of
tissue perfusion independently of vessel size and vascular flow velocity. Perfusion can be
assessed quantitatively, using replenishment kinetics or derivates thereof. Tumor perfusion
is a surrogate parameter for their viability and, moreover, the degree of vascularity of a
tumor can express its aggressiveness and help to predict its response to treatment [30].
Second-generation contrast agents, such as SonoVue® (Bracco Diagnostics, Inc., Milan,
Italy) and Sonazoid® (Daiichi-Sankyo Co., Ltd., Tokyo, Japan), are now commercially
available in North America, Europe, and Asia. SonoVue®, consisting of sulfur hexafluoride
(SF6) within a phospholipid shell, allows visualization of small vessels and microvascular
perfusion in capillary beds and tumors [31].
Images can be directly observed and show vascular detail or may be subjected to
quantitative analysis of specific regions of interest using commercial software, allowing
assessment of perfusion peak intensity, time to peak, persistence within the vascular bed,
and time for complete clearance of the contrast agent [32].
In recent years, several European research groups have reported promising results
of CEUS for the diagnosis of PN and for guiding biopsies both in human and veterinary
medicine.
According to a human study by Halpern et al. [33] in 2012, there are significant benefits
of CEUS compared to a systematic biopsy in distinguishing aggressive PN.
Mitterberger and colleagues reported a higher detection rate of prostate cancer in
humans using CEUS along with Doppler during systematic biopsy [34].
In addition, Frauscher et al. [35] reported a significant increase in the detection rate
of human prostate cancer with CEUS, with a 2.6-fold higher probability than biopsy of
detecting prostate cancer.
Considering the excellent results of CEUS in human medicine, its application has also
recently increased in veterinary medicine.
The work by Russo et al. [36] described the normal perfusion pattern and perfusion
dynamics of the dog prostate, using CEUS.
Interestingly, PN in intact dogs can indeed be detected with CEUS, and there are trends
in perfusion parameters between tumor types. Peak intensity values of perfusion (PPI)
and time to peak (TTP) values are higher in prostatic carcinoma than in leiomyosarcoma.
In cases of prostatic carcinoma, there is hyper-perfusion of the tumor during the wash-
in phase and hypo-echogenicity during the wash-out phase, when compared to normal
dogs. Leiomyosarcoma can be characterized in all phases by a homogeneous anechoic
nonperfused area with surrounding highly vascularized parenchyma [23,32].
The purpose of the present study was to describe the normal perfusion pattern and
perfusion dynamics of prostate gland in castrated dogs with contrast-enhanced ultrasound
and to consider whether this technique might be applicable for the detection of PN in this
group.
2. Materials and Methods
Sixty-four, clinically normal, adult male crossbreed dogs, neutered at least 6 months
prior to the present study, with an average age of approximately 2 to 14 years old and
weighing between 7 and 55 kg, were used in this work.
Consecutive patients were prospectively enrolled from the “Zia Giuseppina” kennel
in Caivano (Naples, Italy), assisted by two veterinary officers, in charge of the health
control of the kennel. All experimental protocols in accordance with the relevant guidelines
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and regulations were approved by the Ethics Committee of the Department of Veterinary
Medicine and Animal Production of the University of Naples, Federico II (protocol code
2016/0090751).
The dogs recruited for the present study underwent a standardized protocol that
included a clinical examination, serum chemistry profile, complete blood cell count, and
urinalysis (data not shown), as well as B-mode and CEUS ultrasound examination of
the prostate. A 20G intravenous, three-way valved catheter was placed in the cephalic
vein to rapidly infuse the bolus dose of freshly prepared contrast agent. The dogs were
positioned in right lateral recumbency and linear (4–18 MHz) and microconvex transducers
(6.6–8.0 MHz - Esaote Mylab 30 gold, Genova, Italy) were used to obtain scans of the
prostate gland. The prostate and iliac lymph nodes were evaluated on the basis of their
size, shape, margins, echogenicity, echotexture, and capsular integrity.
All patients were cooperative and, thus, no sedative or anesthesia was needed.
The transducer was placed at the level of the bladder neck and then moved, caudally,
to visualize the prostate, in the longitudinal plane until a detailed image of the gland was
obtained. The image was then frozen, and the maximal length (L) from the cranial to the
caudal pole of the prostate and the maximal depth (DL) from the dorsal to the ventral part
of the prostate were measured. Then, the transducer was rotated through 90◦ to obtain a
transverse section.
The maximum width (W) and depth (DT) were measured, using the Atalan formulas
(Atalan et al. [37]).
The prostate volume (PV) and the prostate weight (PW) were also calculated using
the Atalan formulas [37].
PV = 0.487 × L × W × (DL + DT)/2 + 6.38. (1)
PW = 0.508 × L × W × (DL + DT)/2 + 3.21. (2)
Data were compared using linear regression analysis with other parameters including
body weight, age, and age at castration, to establish potential relationships, as described
by previous studies in intact dogs [37,38]. Color Doppler examination was performed at a
frame rate of 0.7–1.4 frames per second, to study the prostate gland vascularization. The
probe was then moved dorsally and cranially, to evaluate medial iliac lymph nodes by
B-mode ultrasound.
For the CEUS examination, a second-generation contrast agent SonoVue® (sulfur
hexafluoride microbubbles; Bracco Imaging S.p.A., Milan, Italy) was used in combination
with a 5–7.5 MHz linear transducer with coded harmonic capability and dedicated software
for contrast-enhanced ultrasound analysis (Contrast Tuned Imaging (CnTI-TM), Contrast
Tuned Imaging technology, Esaote, Genova, Italy).
To decrease the acoustic impact of the ultrasound waves on the microbubble contrast
agent and to increase its persistence in the blood flow, the mechanical index was always
less than 0.1 (range 0.05–0.1), corresponding to an acoustic pressure lower than 45 kPa. A
single focal zone was placed in the deepest part of the prostate. The overall gain and time
gain compensation were adjusted, so that no signal from the prostatic parenchyma was
present and only a very low background signal from the prostatic capsule was retained, to
have an anatomical reference in the image.
The contrast agent was injected into the cephalic vein at a dose of 0.03 mL/kg of
prepared solution (5 mg/mL) followed by a rapid bolus of 5 mL of saline solution. The
timer was activated at the moment of the start of the injection (T = 0), and the flow of the
contrast agent into the prostate was observed in real time.
Care was taken to keep the probe in the same position for at least 60 s.
Difficulties occurred in the case of particularly obese dogs, with BCS (Body condition
score) > 4, where the prostate was partly or entirely within the pelvic cavity, and the
operator had to increase the probe pressure to clearly visualize the prostatic margins and
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keep the prostate still in the center of the ultrasound image, for the whole time of the
examination (60 s).
The entire examination was digitally recorded, to be reviewed, so that the enhance-
ment pattern could be analyzed.
A commercial software application, Qontrast® (EC mark nr.0051, class IIA, Bracco,
Milan, Italy) was used to design time–intensity curves. To obtain information, one frame
was selected every 1 s for the first 60 s of the videos. In each sampled frame, the entire
prostate was used as a single region of interest (ROI), manually defined by drawing a line
around the shape of the prostate. A contrast-enhanced time–intensity curve was calculated
for the ROI. The software calculated time–intensity curves on a pixel-by-pixel basis, fitted
them to parametric curves, and calculated the following parameters, starting from T0: PPI
(perfusion peak intensity) expressed as a percentage, TTP (time to peak, starting from T = 0)
expressed in seconds, MTT (medium transit time) expressed in seconds, RBV (regional
blood volume) expressed in cm3, and RBF (regional blood flow) expressed in cm3/s. Mean
values and standard deviations of the previous parameters were then calculated.
Patients were monitored for 2 h after the contrast agent injection, to control and
prevent any side-effects. The whole examination lasted at least 15 min in each dog. There
were eight examinations per day, and they were performed once a week for 8 weeks, in a
total of 64 patients.
Repeated-measures ANOVA was performed to understand whether there was a
difference in PPI percentage values and TTP values at different time points (15 s, 30 s, and
45 s). Greenhouse–Geisser correction was used when Mauchly’s test of sphericity was
violated. When significant interaction effects were observed, post hoc pairwise comparisons
with Bonferroni adjustment were applied to discover which specific means differed.
All analyses were performed using SPSS software version 17.1 for Windows (SPSS
Inc., Chicago, IL, USA), and a p-value <0.05 was considered statistically significant.
3. Results
No physical, laboratory, or ultrasonographic abnormalities and no side-effects or
anaphylactic reactions related to the contrast-enhanced ultrasound examination were
found in any of the 64 examined dogs.
B-mode ultrasound revealed that all the prostate glands had an oval shape with clear
and smooth margins, as well as homogeneous and hypoechoic parenchyma. The urethra
was always visible as anechoic to hypoechoic linear (in longitudinal view) and rounded (in
transverse view) area, surrounded by a hyperechoic wall, which was not always visible
(Figure 1).




Figure 1. B-mode images of the prostate gland (case number 56). (a) Longitudinal view of the prostate gland, which ap-
pears oblong in shape, mildly echogenic, compared to the hypoechoic urethra (evidenced with arrows). (b) Transverse 
view of the same patient, in which the prostate appears ovoidal in shape and, in its center, the hypoechoic circular urethra 
is visible (evidenced with arrows). 
Table 1. Mean and standard deviation of the reported parameters in the 64 dogs. 
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Age at the castration (Months)
Figure 1. B-mode images of the prostate gland (case number 56). (a) Longitudinal view of the prostate gland, which appears
oblong in shape, mildly echogenic, compared to the hypoechoic urethra (evidenced with arrows). (b) Transverse view of the
same patient, in which the prostate appears ovoidal in shape and, in its center, the hypoechoic circular urethra is visible
(evidenced with arrows).
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No focal lesions were discovered in the prostatic parenchyma, and the sizes of the
iliac lymph nodes were within normal limits.
According to the measured parameters, the average prostate volume was 8.48 cm3
± 1.19 (±SD). Mean and standard deviation were calculated for the prostate volume,
weight, age, and age at castration (Table 1). Scatter plots and linear regression analysis were
performed to look for a possible correlation between the average values of the prostate
volume, and the weight, age, and age at castration (Figure 2). No obvious relationship
between prostate volume and the other parameters was found.
Table 1. Mean and standard deviation of the reported parameters in the 64 dogs.
Statistical
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Figure 2. Linear regression analysis was performed to describe a hypothetical correlation between prostate volume and 
other parameters. None of the examined parameters seemed to influence the prostate volume in the 64 castrated dogs: (a) 
relationship between prostate volume and weight; (b) relationship between prostate volume and age at castration; (c) 
relationship between prostate volume and age. 
For CEUS, the wash-in phase was visible after 15 s, when there was homogeneous 
enhancement of the prostatic parenchyma. During the wash-out phase, a homogeneous 
decrease in echogenicity was seen in all cases. The urethra was constantly seen as an echo-
genic linear (longitudinal view) or round (transverse view) area, more intense compared 
to the prostatic parenchyma (Figure 3). 
The flow of the contrast agent was processed using the software Qontrast® (EC mark 
nr.0051, class IIA, Bracco, Milan, Italy), to evaluate perfusion maps and time–intensity 





Figure 3. Contrast-enhanced ultrasound examination: (a) frame at 5 s from T0. The contrast agent has not reached the 
prostate yet, therefore, the gland appears to be still hypo-enhanced; (b) frame at 20 s from T0. The contrast agent is in-






















Figure 2. Linear regression analysis was performed to describe a hypothetical correlation between prostate volume and
other parameters. None of the examined parameters seemed to influence the prostate volume in the 64 castrated dogs:
(a) relationship between prostate volume and weight; (b) relationship between prostate volume and age at castration; (c)
relationship between prostate volume and age.
For CEUS, the wash-in phase was visible after 15 s, when there was homogeneous
enhancement of the prostatic parenchyma. During the wash-out phase, a homogeneous de-
crease in echogenicity was seen in all cases. The urethra was constantly seen as an echogenic
linear (longitudinal view) or round (transverse view) area, more intense compared to the
prostatic parenchyma (Figure 3).
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Figure 3. Contrast-enhanced ultrasound exa ination: (a) fra e at 5 s fro T0. The contrast agent has not reached the
prostate yet, therefore, the gland appears to be still hypo-enhanced; (b) frame at 20 s from T0. The contrast agent is increasing
the gland echogenicity; (c) frame at 33 s from T0. The wash-in phase ends up with a peak enhancement. The prostate
resulted to be hyper-enhanced; (d) frame after 55 s from T0, which represents the wash-out phase. The prostate resulted to
be hypo-enhanced, with respect to the one at 33 s.
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The flow of the contrast agent was processed using the software Qontrast® (EC mark
nr.0051, class IIA, Bracco, Milan, Italy), to evaluate perfusion maps and time–intensity
curves, and the results are shown in Table 2.
Table 2. Mean and standard deviation of the CEUS parameters calculated using the Q-contrast
software in the prostates of the 64 examined dogs. PPI, perfusion peak intensity; TTP, time to peak;
MTT, medium transit time; RBV, regional blood volume; RBF, regional blood flow.
Statistical Variables PPI (%) TTP (s) RBV (cm3) RBF (cm3/s) MTT (s)
Mean 45.29 34.07 3192.62 56.19 54.26
Standard Deviation 8.19 7.93 1723.20 13.78 21.35
A repeated-measures ANOVA with Greenhouse–Geisser correction determined that
mean values of PPI percentages differed statistically significantly between time points
(F = 6.00, p < 0.01). Post hoc tests using the Bonferroni correction revealed that there were
no significant differences between the PPI average values described at 15 s and those at
45 s (p = 0.23), nor between the average PPI values at 30 s and those at 45 s (p = 0.51).
However, at 30 s, average PPI values increased to 41.17% ± 9.53%, which was statisti-
cally significantly different to those at 15 s (p < 0.001). Therefore, we can conclude that a
wait of 15 s from the first measurement resulted in an increase in PPI percentage (Figure 4).
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The same statistical analysis was performed in order to find significant differences at
the three time points for TTP mean values (Figure 5), but the TTP analysis did not result
significant (p = 0.299).
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rela ively easy to determine prostate size using linear measu men s of prostate heig t,
wid h, or le gth, or to estimate pros ate volume [39–41], there is still debate about the
exact relationship between the pr sta e gland s ze and the canine body weight in in ct
dogs [37,38], possibly due to the potenti complication of age- elated changes in prostate
volume [42,43]. In the work y Atalan et al. [37], it was demonstrated that prostatic wei ht
and volume were rel t d to body weight and ge in intact dogs but not in neu ered dogs.
However, since prostate volume was only measured in two neutered dogs in that study, no
statistical analyses were performed on prostate volume and other parameters in this group.
rc i ecto y ca ses a si ifica t re cti i t e r static i e si , e i i
soon after 7–14 days, and reaching 70 of the entire volu e of the gland in 6 onths [7].
onetheless, none of the previous studies provided a reference range for prostate volu e
in neutered dogs. In the present study, we found that prostate size did not appear to
be related to body mass in neutered dogs, and the average of the prostatic volume was
8.48 cm3 ± 1.19 (±SD).
To determine the normal range of prostatic volume found in healthy neutered dogs, it
was important to examine a cohort of 64 adult castrated dogs (age 2 to 14 years and weight
7–55 kg) with no clinical signs of prostatic diseases. There was no apparent correlation
between weight, age, and age at castration, and prostate volume, suggesting that, in
neutered dogs, the prostate volume is not influenced by any of the previous parameters.
Nonetheless, due to the low sample size, further studies are needed on a larger number of
castrated dogs, to establish a recognized reference range.
The prostate may succumb to both focal and diffuse parenchyma changes, which may
be hyperechoic, hypoechoic, or of mixed echogenicity. These changes are also nonspecific
and require further investigation, which may include Doppler or contrast-enhanced ultra-
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sound imaging [32]. Color Doppler evaluation appears to be useful for the assessment of
the vascularity in intact dogs, but it is unsuccessful in neutered dogs because of the reduced
prostate vessel diameter. Flow within intratumoral neovessels (10–40 µm diameter) may
also be below the resolution of conventional Doppler ultrasound. This hypothesis could be
supported by our study, where, despite using low PRF (pulse repetition frequency), which
increases the detection of slow vascular flow, the prostatic artery and its branches could
not be seen.
CEUS, however, allows the visualization of microvascularization, making it an inter-
esting and promising diagnostic tool for the evaluation of the prostate especially within the
castrated dogs, where vessel size is smaller than that in intact ones. In human medicine,
CEUS is a well-established technique for the diagnosis of PN. A study by Unal et al. [44]
described that CEUS detected 68–79% of all tumor foci larger than 5 mm, leading the
authors to conclude that CEUS was the best single diagnostic tool for prostate carcinoma
detection. Our investigation produced detailed prostatic perfusion patterns, which can
serve as a normal dataset of prostatic appearance in neutered dogs and which can possibly
be used as an early diagnostic method for detecting focal lesions related to PN.
Real-time contrast study allowed a better and detailed visualization of the prostatic
gland vascularization than color Doppler examination. Nonetheless, since the qualitative
analysis results are subjective, to perform an objective evaluation of the perfusion kinetics,
collected data were standardized with a dedicated contrast-enhanced ultrasound analytical
software (Q-contrast, Bracco, Italy), allowing the collection of all parameters obtained by
perfusion maps and time–intensity curves. The most significant perfusion parameters
were PPI (perfusion peak intensity) and TTP (time to peak). In particular, the PPI average
was 45.2% (±8.2%), while TTP average was 34.1 s (±7.9 s). Intact dogs had a PPI average
of 16.8% and a TTP average of 33.6 s [36]. Vignoli et al. [23] evidenced that there were
no significant differences in prostatic perfusion in dogs with benign prostatic pathology
compared with normal dogs, while, in dogs affected by prostatic adenocarcinoma, the PPI
average was 23.7% and the TTP average was 26.9 s, suggesting that intratumoral vessels
resulted in an increased, faster enhancement of the contrast agent.
PPI calculated in neutered dogs was higher than that calculated in healthy intact dogs,
while TTP values were quite similar. A possible explanation for the higher PPI value could
be related to the gradual parenchymal reduction, due to the previous castration, which
does not change the vascularity of the prostate, thereby increasing the intensity of the
ultrasound contrast agent.
To analyze the PPI and TTP variance trends in castrated dogs, means for PPI and TTP
were further calculated at three different time points. Some necessary adjustments to the
analysis models were included, to take into account specific features of the population.
In particular, Greenhouse–Geisser correction (GGc) adjusts for the lack of sphericity in
repeated-measures ANOVA. In this case, the p-value results were lower than 0.005. Taking
multiple samples, then, the PPI in castrated dogs was coherent 99% of the time with
the results found in our work, in contrast to TTP, whose p-value was 0.299, showing no
significance of the coefficients. Further analysis was conducted to verify the existence of
significant differences at the three time points. Results were significant when looking at
the difference between 15 and 30 s. Interestingly, coefficients for PPI at 30 and 45 s were
not statistically different. Lastly, TTP parameters showed no significant differences across
all time sets. Further studies on a higher number of samples should be performed to
standardize PPI and TTP parameters in the prostate of castrated dogs.
In the present study, none of the 64 examined dogs showed any focal or multifocal
lesions related to PN, despite the literature reporting a higher incidence in neutered dogs. It
has been reported that targeted biopsies during CEUS increase the detection rate of human
prostate cancer [45]. In neutered dogs, we believe that targeted biopsies during CEUS can
be used to reduce the number of core biopsies and to establish clear diagnostic samples.
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5. Conclusions
In conclusion, CEUS seems to be a sensitive diagnostic tool compared to B-mode
ultrasound in the analysis of prostatic features in castrated dogs.
The continued advances made in diagnostic imaging technology have led to substan-
tial improvement in disease investigation, and it appears that contrast-enhanced ultrasound
imaging in particular will significantly improve our ability to diagnose prostatic pathology
in neutered dogs.
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